Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,354.68 -50.98 (-0.13%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
60,141.25 -3,359.95 (-5.29%) CMC Crypto 200
1,290.95 -48.12 (-3.59%)
Certara, Inc. (CERT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 17.08 |
| Open | 16.89 |
| Bid | 17.06 x 200 |
| Ask | 17.13 x 200 |
| Day's range | 16.85 - 17.34 |
| 52-week range | 11.81 - 23.85 |
| Volume | |
| Avg. volume | 523,998 |
| Market cap | 2.741B |
| Beta (5Y monthly) | 1.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares
Certara Inc (NASDAQ:CERT), a global leader in biosimulation, provides software, consulting, and technology-enabled services to support drug discovery, development, and regulatory science.
- Simply Wall St.
Certara, Inc.'s (NASDAQ:CERT) Intrinsic Value Is Potentially 66% Above Its Share Price
Key Insights The projected fair value for Certara is US$29.68 based on 2 Stage Free Cash Flow to Equity Current share...
- Zacks
Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
Puma Biotechnology (PBYI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
© 2024 Yahoo. All rights reserved.